Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Katie G Owings"'
Publikováno v:
G3: Genes, Genomes, Genetics, Vol 12, Iss 6 (2022)
AbstractVariation in the onset, progression, and severity of symptoms associated with metabolic disorders such as diabetes impairs the diagnosis and treatment of at-risk patients. Diabetes symptoms, and patient variation in these symptoms, are attrib
Externí odkaz:
https://doaj.org/article/118509f626e04105b57ce8e7ee0305a6
Autor:
Dana M Talsness, Katie G Owings, Emily Coelho, Gaelle Mercenne, John M Pleinis, Raghavendran Partha, Kevin A Hope, Aamir R Zuberi, Nathan L Clark, Cathleen M Lutz, Aylin R Rodan, Clement Y Chow
Publikováno v:
eLife, Vol 9 (2020)
N-Glycanase 1 (NGLY1) is a cytoplasmic deglycosylating enzyme. Loss-of-function mutations in the NGLY1 gene cause NGLY1 deficiency, which is characterized by developmental delay, seizures, and a lack of sweat and tears. To model the phenotypic variab
Externí odkaz:
https://doaj.org/article/b15615d75fd24af79e4e3c0481b7aa57
Autor:
Rebecca A.S. Palu, Kaitlyn Stevens, Elaine Ong, Shani Chung, Clement Y. Chow, Katie G Owings, Alan G. Goodman
Publikováno v:
G3: Genes, Genomes, Genetics, Vol 9, Iss 12, Pp 3995-4005 (2019)
Apoptosis is the primary cause of degeneration in a number of neuronal, muscular, and metabolic disorders. These diseases are subject to a great deal of phenotypic heterogeneity in patient populations, primarily due to differences in genetic variatio
Autor:
Katie G. Owings, Rebecca A.S. Palu
Variation in the onset, progression, and severity of symptoms associated with metabolic disorders such as diabetes impairs the diagnosis and treatment of at-risk patients. Diabetes symptoms, and patient variation in these symptoms, is attributed to a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::58230a9a6587a55f03eea765c9a4d060
https://doi.org/10.1101/2021.09.13.460173
https://doi.org/10.1101/2021.09.13.460173
Autor:
Kevin A. Hope, Cathleen M. Lutz, Aylin R. Rodan, Dana M Talsness, Clement Y. Chow, Gaelle Mercenne, Raghavendran Partha, John M. Pleinis, Emily Coelho, Aamir Zuberi, Nathan L. Clark, Katie G Owings
Publikováno v:
eLife, Vol 9 (2020)
eLife
eLife
N-Glycanase 1 (NGLY1) is a cytoplasmic deglycosylating enzyme. Loss-of-function mutations in the NGLY1 gene cause NGLY1 deficiency, which is characterized by developmental delay, seizures, and a lack of sweat and tears. To model the phenotypic variab
Autor:
Kevin A. Hope, Aamir Zuberi, Aylin R. Rodan, Raghavendran Partha, Katie G Owings, Dana M Talsness, Emily Coelho, John M. Pleinis, Gaelle Mercenne, Clement Y. Chow, Nathan L. Clark, Cathleen M. Lutz
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc28d4119d21c2320509b791be89a5d8
https://doi.org/10.7554/elife.57831.sa2
https://doi.org/10.7554/elife.57831.sa2
Autor:
Aylin R. Rodan, Raghavendran Partha, Katie G Owings, Emily Coelho, Nathan L. Clark, Cathleen M. Lutz, Aamir Zuberi, Clement Y. Chow, Gaelle Mercenne, Dana M Talsness, John M. Pleinis
N-Glycanase 1 (NGLY1) is a cytoplasmic deglycosylating enzyme. Loss-of-function mutations in theNGLY1gene cause NGLY1 deficiency, which is characterized by developmental delay, seizures, and a lack of sweat and tears. To model the phenotypic variabil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ece188007ab0c5db7856b4541320e3c9
Publikováno v:
Human Molecular Genetics. 27:1055-1066
Autosomal recessive loss-of-function mutations in N-glycanase 1 (NGLY1) cause NGLY1 deficiency, the only known human disease of deglycosylation. Patients present with developmental delay, movement disorder, seizures, liver dysfunction and alacrima. N
Autor:
Rebecca A. S. Palu, Elaine Ong, Kaitlyn Stevens, Shani Chung, Katie G. Owings, Alan G. Goodman, Clement Y. Chow
Publikováno v:
G3: Genes, Genomes, Genetics, Vol 9, Iss 12, Pp 3995-4005 (2019)
Externí odkaz:
https://doaj.org/article/4545784ddd644bcea663b88220665b90